Pyrin—the protein involved in FMF—has a role in activating the proinflammatory cytokine interleukin (IL)-1β and colchicine is the only known treatment in this disease but nearly 5–10% of patients are resistant to colchicine [100]. The gene discussed is IL1B; the disease is familial Mediterranean fever.